Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free ENVB Stock Alerts

Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume

Enveric Biosciences logo
$2.29 -0.15 (-6.15%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$2.23 -0.06 (-2.62%)
As of 05:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Enveric Biosciences Short Interest Overview

As of April 30, 2026, Enveric Biosciences (ENVB) had a short interest of 886,509 shares sold short, representing 45.77% of the public float. This marks a 1,306.64% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.0, meaning it would take 0.0 days of the average trading volume of 11.80 million shares to cover all short positions.

Current Short Interest
886,509 shares
Previous Short Interest
63,023 shares
Change Vs. Previous Month
1,306.64%
Dollar Volume Sold Short
$3.50 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
1,985,000 shares
Short Percent of Float
45.77%
Today's Trading Volume
172,107 shares
Average Trading Volume
11,802,738 shares
Today's Volume Vs. Average
1%
Short Selling Enveric Biosciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ENVB Short Interest Over Time

ENVB Days to Cover Over Time

ENVB Percentage of Float Shorted Over Time

Enveric Biosciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026886,509 shares $3.50 million +1,306.6%45.8%0.04 $3.95
4/15/202663,023 shares $127.94 thousand -10.9%3.4%2.29 $2.03
3/31/202670,703 shares $137.16 thousand -24.8%3.8%2.22 $1.94
3/13/202693,975 shares $178.55 thousand -20.6%6.8%1.79 $1.90
2/27/2026118,369 shares $278.17 thousand +90.8%8.6%0.06 $2.35
2/13/202662,034 shares $130.27 thousand -20.0%4.5%1.31 $2.10
1/30/202677,515 shares $225.57 thousand +14.5%13.0%1.01 $2.91
1/15/202667,685 shares $276.15 thousand +7.9%11.4%1.47 $4.08
12/31/202562,720 shares $227.67 thousand -45.0%10.6%0.75 $3.63
12/15/2025114,023 shares $611.16 thousand +161.4%19.2%0.03 $5.36
11/28/202543,623 shares $254.10 thousand -39.2%7.3%1.33 $5.83
11/14/202571,782 shares $379.01 thousand +136.9%14.0%0.34 $5.28
10/31/202530,303 shares $172.73 thousand -84.9%5.9%0.66 $5.70
10/15/2025200,600 shares $180.56 thousand -35.0%3.7%0.4 $0.90
9/30/2025308,600 shares $197.32 thousand -18.3%5.7%0.8 $0.64
9/15/2025377,900 shares $355.34 thousand -5.0%13.4%1.2 $0.94
8/31/2025397,600 shares $449.29 thousand +71.1%14.1%1.9 $1.13
8/15/2025232,400 shares $255.64 thousand -8.9%8.2%1.4 $1.10
7/31/2025255,100 shares $311.22 thousand +19.5%11.9%1 $1.22
7/15/2025213,500 shares $262.61 thousand -20.6%10.0%0.9 $1.23
6/30/2025269,000 shares $325.49 thousand +17.8%12.6%1.3 $1.21
6/15/2025228,400 shares $276.36 thousand -25.0%10.7%1.1 $1.21
5/31/2025304,600 shares $356.41 thousand +143.3%14.2%1.5 $1.17
5/15/2025125,200 shares $157.75 thousand -27.2%5.9%0 $1.26
4/30/2025172,000 shares $227.04 thousand -1.3%7.0%0.1 $1.32
4/15/2025174,200 shares $216.48 thousand -3.0%7.5%0.1 $1.24
3/31/2025179,500 shares $249.51 thousand -25.6%7.7%0.1 $1.39
3/15/2025241,100 shares $417.10 thousand -80.6%13.3%0.1 $1.73
2/28/20251,240,000 shares $3.47 million +351.4%77.5%0.5 $2.80
2/15/2025274,700 shares $439.52 thousand +17.8%15.2%0.1 $1.60
1/31/2025233,200 shares $487.39 thousand -42.8%16.9%1.5 $2.09
1/15/2025407,400 shares $145.44 thousand +498.2%4.3%0.8 $0.36
12/31/202468,100 shares $24.41 thousand -56.7%0.7%0.1 $0.36
12/15/2024157,200 shares $57.14 thousand +36.1%1.7%0.3 $0.36
11/30/2024115,500 shares $38.12 thousand -57.6%1.2%0.2 $0.33
11/15/2024272,200 shares $100.71 thousand -17.6%3.0%0.5 $0.37
10/31/2024330,200 shares $164.84 thousand +70.9%4.1%0.7 $0.50
10/15/2024193,200 shares $81.72 thousand -2.9%2.4%0.1 $0.42
9/30/2024199,000 shares $94.33 thousand -2.8%2.3%0.2 $0.47
9/15/2024204,700 shares $102.55 thousand -38.3%2.3%0.2 $0.50
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

See the 5 stocks to avoid
8/31/2024332,000 shares $168.46 thousand -29.2%3.8%0.3 $0.51
8/15/2024469,100 shares $226.58 thousand -80.9%5.3%0.4 $0.48
7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47
7/15/2024131,700 shares $71.38 thousand -13.4%1.7%0.2 $0.54
6/30/2024152,100 shares $95.25 thousand -43.4%2.0%0.3 $0.63
6/15/2024268,800 shares $198.91 thousand -20.5%3.5%0.5 $0.74
5/31/2024338,100 shares $263.72 thousand -50.2%4.5%0.2 $0.78
5/15/2024678,900 shares $534.97 thousand +736.1%8.9%0.1 $0.79
4/30/202481,200 shares $76.33 thousand -15.1%1.1%0 $0.94
4/15/202495,600 shares $88.10 thousand -62.5%1.4%0 $0.92
3/31/2024254,900 shares $254.90 thousand +69.5%4.2%0.1 $1.00
3/15/2024150,400 shares $162.43 thousand +58.2%3.2%0 $1.08
2/29/202495,100 shares $137.90 thousand +47.0%4.2%0 $1.45
2/15/202464,700 shares $54.28 thousand +181.3%2.5%0.2 $0.84
1/31/202423,000 shares $16.93 thousand -58.6%0.9%0.2 $0.74
1/15/202455,600 shares $71.17 thousand +334.4%2.3%1.4 $1.28
12/31/202312,800 shares $16.64 thousand +6.7%0.6%0.4 $1.30
12/15/202312,000 shares $16.08 thousand +263.6%0.6%0.7 $1.34
11/30/20233,300 shares $4.88 thousand -54.8%0.2%0.2 $1.48
11/15/20237,300 shares $10.40 thousand -62.4%0.4%0.4 $1.43
10/31/202319,400 shares $33.37 thousand -19.5%1.0%0.9 $1.72
10/15/202324,100 shares $50.85 thousand +121.1%1.3%0.3 $2.11
9/30/202310,900 shares $25.94 thousand -55.0%0.6%0.1 $2.38
9/15/202324,200 shares $55.18 thousand -45.3%1.2%0.3 $2.28
8/31/202344,200 shares $95.47 thousand -42.3%2.3%0.4 $2.16
8/15/202376,600 shares $182.31 thousand +86.4%4.0%0.1 $2.38
7/31/202341,100 shares $109.74 thousand +95.7%2.2%0 $2.67
7/15/202321,000 shares $60.27 thousand -43.1%1.1%0 $2.87
6/30/202336,900 shares $124.35 thousand -65.6%2.0%0 $3.37
6/15/2023107,400 shares $414.56 thousand -69.1%5.8%0 $3.86
5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19
5/15/202322,700 shares $34.05 thousand -30.2%1.2%0 $1.50
4/30/202332,500 shares $59.52 thousand +44.4%1.8%1 $1.83
4/15/202322,500 shares $34.20 thousand +39.8%1.2%0.6 $1.52
3/31/202316,100 shares $26.79 thousand +64.3%0.9%0.6 $1.66
3/15/20239,800 shares $16.95 thousand +71.9%0.6%0.3 $1.73
2/28/20235,700 shares $11.91 thousand -38.0%0.3%0.1 $2.09
2/15/20239,200 shares $24.93 thousand -37.8%0.5%0.2 $2.71
1/31/202314,800 shares $42.48 thousand -53.6%0.8%0.3 $2.87
1/15/202331,900 shares $90.28 thousand -21.2%1.7%0.7 $2.83
12/30/202240,500 shares $84.24 thousand -11.2%2.0%0.7 $2.08
12/15/202245,600 shares $97.58 thousand +27.4%2.3%0.9 $2.14
11/30/202235,800 shares $102.75 thousand -17.5%1.8%0.5 $2.87
11/15/202243,400 shares $147.56 thousand -37.7%2.2%0.4 $3.40
10/31/202269,700 shares $237.68 thousand +36.1%4.7%0.3 $3.41
10/15/202251,200 shares $175.10 thousand +55.2%3.6%0.1 $3.42
9/30/202233,000 shares $139.26 thousand -60.1%2.3%0.1 $4.22
9/15/202282,800 shares $477.76 thousand +11.7%5.8%0.2 $5.77
8/31/202274,100 shares $413.48 thousand -21.7%5.4%0.2 $5.58
8/15/202294,600 shares $624.36 thousand -43.4%6.9%0.2 $6.60
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

See the 5 stocks to avoid
7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40
7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00
6/30/20222,360,000 shares $505.75 thousand -23.9%N/A0.9 $0.21
6/15/20223,100,000 shares $651 thousand -4.6%N/A1.6 $0.21
5/31/20223,250,000 shares $642.53 thousand -2.1%N/A1.5 $0.20
5/15/20223,320,000 shares $664 thousand -2.4%N/A1.1 $0.20
4/30/20223,400,000 shares $918.34 thousand +165.6%N/A1 $0.27
4/15/20221,280,000 shares $384.38 thousand -19.5%N/A0.4 $0.30
3/31/20221,590,000 shares $524.70 thousand -17.6%N/A0.6 $0.33
3/15/20221,930,000 shares $536.54 thousand +498.1%N/A0.8 $0.28
2/28/2022322,700 shares $88.58 thousand -67.6%N/A0.1 $0.27
2/15/2022996,300 shares $313.83 thousand +421.9%N/A0.8 $0.32
1/31/2022190,900 shares $121.47 thousand -67.1%N/A0.3 $0.64
1/15/2022580,200 shares $434.45 thousand +143.0%N/A0 $0.75
12/31/2021238,800 shares $222.08 thousand -41.9%N/A0.3 $0.93
12/15/2021411,300 shares $435.98 thousand -50.8%N/A0.3 $1.06
11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30
11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80
10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76
10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89
9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07
9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65
8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99
8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72
7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91
7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06
6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38
6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21
5/28/20211,060,000 shares $2.36 million +183.1%6.5%0.4 $2.23

ENVB Short Interest - Frequently Asked Questions

Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 886,509 shares of ENVB short. 45.77% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 0.0. Learn More on Enveric Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 45.77% of Enveric Biosciences' floating shares are currently sold short.

Enveric Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 886,509 shares, an increase of 1,306.6% from the previous total of 63,023 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

45.77% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enveric Biosciences: ABVC BioPharma, Inc. (1.25%), Marker Therapeutics, Inc. (0.96%), Barinthus Biotherapeutics PLC Sponsored ADR (0.02%), Lantern Pharma Inc. (19.49%), VistaGen Therapeutics, Inc. (4.57%), TherapeuticsMD, Inc. (0.50%), Akanda Corp. (66.60%), VYNE Therapeutics Inc. (0.37%), Novogen Limited (24.95%), Pasithea Therapeutics Corp. (1.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ENVB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ENVB) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel